Lancet Infectious Diseases Study Compare Well With Phase 3 Clinical Trials Of COVAXIN: Bharat Biotech
On the study conducted by the Lancet Infectious Diseases on the effectiveness of COVAXIN (BBV152) against symptomatic RT-PCR, Bharat Biotech the Hyderabad based company commented and has compared the results…
Share